A growing world needs Canadian oil and natural gas, even in a lower-carbon environment
Oct 10, 2017 11:03 am UTC| Business
WINNIPEG, Manitoba, Oct. 10, 2017 -- Population growth around the world is increasing demand for more energy in every form, creating a chance for Canada both to share its energy prosperity abroad and drive to a...
Oct 10, 2017 11:01 am UTC| Business
Arix Bioscience notes positive Phase I clinical and non-clinical data from Amplyx for the treatment of life-threatening fungal infections LONDON, 10 October 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience"),...
DSP Group Inc.’s Third Quarter 2017 Earnings Release and Conference Call
Oct 10, 2017 11:00 am UTC| Business
LOS ALTOS, Calif., Oct. 10, 2017 -- DSP Group® Inc. (NASDAQ:DSPG), will release its earnings results for the third quarter of 2017 on November 2nd, 2017 before market opens. The company would like to invite you to...
Oct 10, 2017 11:00 am UTC| Business
IV Meloxicam 30mg Demonstrates Statistically Significant Reductions in Pain, Along with Reductions in Opioid Rescue Use and Improvements in Several Other Pain Relief Metrics Selected as a “Top 6” Poster at the Meeting ...
Horizon Pharma plc to Host Third-Quarter 2017 Conference Call and Webcast on Nov. 6, 2017
Oct 10, 2017 11:00 am UTC| Business
DUBLIN, Ireland, Oct. 10, 2017 -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and...
Apricus Biosciences to Present at the 2017 BIO Investor Forum
Oct 10, 2017 11:00 am UTC| Business
SAN DIEGO, Oct. 10, 2017 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard Pascoe, Chief Executive Officer,...
Oct 10, 2017 11:00 am UTC| Business
BOSTON, Oct. 10, 2017 -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by metabolic diseases, announced today...